BioLife Solutions, Inc. Business Acquisition, Pro Forma Revenue
BioLife Solutions, Inc. (BLFS) reported Business Acquisition, Pro Forma Revenue of $37.73 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-15.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2020-05-15
- BioLife Solutions, Inc. business acquisition, pro forma revenue for fiscal 2019 was $37.73M, a 16.61% increase from fiscal 2018.
- BioLife Solutions, Inc. business acquisition, pro forma revenue for fiscal 2018 was $32.35M.
| Period end | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|
| 2019-12-31 | $37.73M 10-K · filed 2020-05-15 |
| 2018-12-31 | $32.35M 10-K · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |